Medizone Home
×

Thanks for visiting us at Expopharm 2018!

Thank you for visiting us at Expopharm in Munich this year. It was a great pleasure to have the opportunity again to speak in person with many of our business partners. One big subject was the safety of ...

CHMP approves pegfilgrastim biosimilar, Pelgraz from Accord/Intas

Pelgraz – a pegylated G-CSF biosimilar, is latest addition to Accord Healthcare’s established portfolio of over 30 oncology treatments across Europe. Following marketing authorisation Accord Healthcare ...

FDA approves Mylan and Biocon’s Fulphila, the first biosimilar to Neulasta

Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Mylan’s Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim), co-developed with ...